Ocugen announced that its co-development partner, Bharat Biotech, announced the results of the first interim analysis of its Phase III study of Covaxin, a whole virion inactivated COVID-19… read more.
Interview and article by Christine Clark Dr Mark Tomlin, consultant critical care pharmacist, describes how recent trial findings have identified effective treatments for the systemic inflammatory response syndrome… read more.
Interview and article by Christine Clark Although SARS-CoV-2 causes a mild illness in many people, some experience severe illness characterised by a systemic inflammatory response that can lead… read more.
Pfizer Inc.and BioNTech SE announced they have begun an evaluation of the safety and immunogenicity of a third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the… read more.
To ensure an effective global immunisation strategy against COVID-19, vaccines need to be produced at scale, priced affordably, and allocated globally so that they are available where needed,… read more.
Verify Diagnostics announced that Health Canada has authorized the Assure Tech Ecotest COVID-19 serological rapid test to be used at the point-of-care (POC) for the purpose of screening… read more.
Pfizer Inc. and BioNTech SE announced the submission of new data to the FDA demonstrating the stability of their COVID-19 vaccine when stored at -25°C to -15°C (-13°F… read more.
Interview and article by Christine Clark Dr Maureen Spargo and Dr Nicola Goodfellow describe how SHAPES, a pan-European digital healthcare project is being put into action in Northern… read more.
AstraZeneca’s COVID-19 vaccine has been granted Emergency Use Listing (EUL) by the World Health Organization (WHO) for active immunisation to prevent COVID-19 in individuals 18 years of age… read more.
Article written by Bruve Sylvester Covid-19 patients treated with preventive blood thinning drugs (prophylactic anticoagulants) within 24 hours of admission to hospital have lower subsequent mortality than covid-19… read more.
Article written by Bruce Sylvester Researchers report that ivabradine, a drug used for heart failure, appears to improve symptoms of postural orthostatic tachycardia syndrome, also known as POTS.
Sinovac Biotech has announced phase III results of CoronaVac in COVID-19 treatment.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.
